Table 1 Demographic and clinical characteristics of the ICG-R15 < 14% and ICG-R15 ≥ 14% groups
Characteristic | ICG-R15 < 14% group (n = 50) | ICG-R15 ≥ 14% group (n = 19) | p value |
|---|---|---|---|
Patients | |||
 Age, years (range) | 58 ± 10 (38–81) | 59 ± 9 (38–74) | 0.746 |
 Sex (male/female) | 45:5 | 11:8 | *0.007 |
 BMI (kg/m2) | 23.5 ± 2.9 | 24.2 ± 3.2 | 0.378 |
Etiology (%) | Â | Â | 0.3923 |
 Hepatitis B virus | 38 (76.0) | 17 (89.4) |  |
 Hepatitis C virus | 3 (6.0) | 1 (5.3) |  |
 Other | 9 (18.0) | 1 (5.3) |  |
Laboratory results | |||
 ALB (g/L) | 40.04 ± 4.18 | 35.89 ± 9.49 | 0.080 |
 PAB (mg/L) | 205.88 ± 51.68 | 117.63 ± 45.19 | * < 0.001 |
 TB (μmol/L) | 19.67 ± 12.56 | 22.26 ± 9.75 | 0.420 |
 AST (U/L) | 28 (23, 48.5) | 38 (28, 61) | 0.090 |
 ALT (U/L) | 28 (20, 49.25) | 26 (19, 36) | 0.282 |
 PLT (× 109/L) | 144.68 ± 55.43 | 97.00 ± 49.91 | *0.002 |
 PT (s) | 12.24 ± 0.92 | 13.98 ± 1.37 | * < 0.001 |
 INR | 1.04 ± 0.08 | 1.19 ± 0.12 | * < 0.001 |
MRE parameters | |||
 Liver c (m/s) | 1.81 ± 0.29 | 2.39 ± 0.45 | * < 0.001 |
 Liver φ (rad) | 0.75 ± 0.11 | 0.86 ± 0.11 | *0.001 |